Cidara Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
(NASDAQ:CDTX), SAN DIEGO, July 01, 2025 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company applying its proprietary Cloudbreak(R) platform to develop drug-Fc conjugate (DFC) therapeutics, today announced that the Compensation and Human Capital Committee of its Board of Directors (Compensation Committee) granted non-qualified stock option awards and restricted stock units (RSUs) for […]